AgroAmerica Ranks Among the Top 10 of the Most Transparent Companies in Sustainable Palm Oil Practices in the World
10.11.2020 20:47:00 EET | Business Wire | Press release
AgroAmerica ranked as the 7th sustainable company out of 100 oil palm companies in the world. This year the company received a rating of 84.95% in the latest Sustainability Policy Transparency Toolkit (SPOTT) Assessment recently released by the UK-based Zoological Society of London (ZSL).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201110006035/en/
AgroAmerica ranked in the top 10 out of 100 palm oil producers, processors, and traders on the public disclosure of their policies, operations, and commitments to environmental, social, and governance (ESG) best practice, in the results published by the renowned SPOTT Transparency evaluation. On the image, one of the most notable AgroAmerica's conservation project, The Maya Biosphere Conservation Project, that promotes the protection of 19,000+ hectares of land and the biodiversity of the area. (Photo: Business Wire)
The SPOTT platform promotes the transparency of companies by disclosing their policies, practices, and commitments related to environmental, social, and governance issues.
Fernando Bolaños, CEO of AgroAmerica, said that this is the third consecutive year that AgroAmerica participates in this sustainability evaluation, intending to improve, year after year, its practices and commitments, and continue to offer food products sustainably produced and distributed.
SPOTT evaluates 180 indicators grouped into 10 categories: Sustainability and leadership; Landbank, maps and traceability; Certification standards; Deforestation and biodiversity; HCV, HCS and impact assessments; Peat, fire and GHG emissions; Water, chemical and pest management; Community, land and labor rights; Smallholders and suppliers; Governance and grievances.
The evaluation aims to measure the progress of companies towards sustainable production and marketing of palm oil. Among the most notable results, AgroAmerica obtained the complete qualification in HCV, HCS and impact assessments, for its commitment to the conservation of ecosystems, especially in areas of High Conservation Value.
Additionally, its commitment to zero deforestation and the use of technological tools for the optimization of natural resources, as well as the implementation of programs and projects for compliance with labor and land rights and the verifiable establishment of good relations with communities, allowed AgroAmerica to be among the top 10 of the companies evaluated in the transparency ranking.
The SPOTT evaluation team, comprised of professionals from prestigious London universities, belongs to ZSL, and is part of the Palm Oil Roundtable (RSPO).
“Participating in this evaluation is part of our policy of being transparent in our sustainable production practices and reaffirming our commitment to comply with international standards, which leads us to differentiate ourselves and have a competitive advantage in the oil palm sector, as well as promote a sustainable production and trade, ”stated Bolaños.
About AgroAmerica
AgroAmerica is an agro-industrial company dedicated to the production and commercialization of food products, through sustainable and responsible methods. Our company has operations in Europe, the United States, Mexico, Guatemala, Ecuador, Peru, and Panama.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201110006035/en/
Contact information
Javier Aguirre
Corporate Director
comunicacion@agroamerica.com
(502) 2420-9600
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom